Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Distinct requirements for IFNs and STAT1 in NK cell function.

C K Lee1, D T Rao, R Gertner

  • 1Department of Pathology, Kaplan Comprehensive Cancer Center, New York University School of Medicine, NY 10016, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|October 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A catalogue of anomalies and traits of the primary dentition of southern Chinese.

The Journal of clinical pediatric dentistry·2008
Same author

Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation.

AJNR. American journal of neuroradiology·2008
Same author

Optical configuration and color-representation range of a variable-pitch dot matrix holographic printer.

Applied optics·2008
Same author

Cylindrical-type nanometer-resolution laser diffractive optical encoder.

Applied optics·2008
Same author

Retroperitoneal extralobar pulmonary sequestration mimicking a pheochromocytoma.

Histopathology·2008
Same author

Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes.

Rheumatology (Oxford, England)·2008

Signal transducer and activator of transcription 1 (STAT1) is crucial for natural killer (NK) cell antitumor activity. STAT1 deficiency impairs NK cell function, highlighting the importance of STAT1 in maintaining NK cell-mediated tumor rejection.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Natural killer (NK) cells are critical immune cells involved in tumor surveillance and rejection.
  • Interferon (IFN) signaling pathways, particularly those mediated by Signal transducer and activator of transcription 1 (STAT1), play a significant role in regulating immune cell function.
  • The precise role of STAT1 in NK cell-mediated antitumor immunity requires further elucidation.

Purpose of the Study:

  • To investigate the function of NK cells in mice with a targeted mutation of the STAT1 gene.
  • To determine the impact of STAT1 deficiency on NK cell cytolytic activity and in vivo tumor rejection.
  • To elucidate the specific roles of type I and type II interferons in STAT1-dependent NK cell antitumor responses.

Main Methods:

Related Experiment Videos

  • Analysis of NK cell functions in STAT1-deficient (STAT1(-/-)) mice and wild-type littermates.
  • In vitro assessment of NK cell cytolytic activity using various stimuli (IL-12, poly(I:C)).
  • In vivo tumor rejection assays using NK-sensitive tumors (RMA-S) in STAT1(-/-) mice, with and without cytokine treatment.
  • Examination of the expression of key NK cell activation and lytic molecules (granzyme A, granzyme B, perforin, DAP10, DAP12).

Main Results:

  • STAT1(-/-) mice exhibited impaired basal NK cell cytolytic activity in vitro and failed to reject transplanted tumors in vivo.
  • NK cell numbers were normal in STAT1(-/-) mice, and the expression of molecules essential for cytolytic function was intact.
  • While IL-12 enhanced NK cell-mediated cytolysis, poly(I:C) did not, suggesting a specific defect in IFN signaling.
  • NK cells derived from STAT1(-/-) progenitors showed normal responses to IL-15, but STAT1(-/-) mice still could not reject tumors even after IL-12 treatment.
  • Mice lacking both type I and type II IFN receptors resisted tumor challenge, despite reduced in vitro NK cytolysis.

Conclusions:

  • STAT1 is essential for maintaining NK cell function and mediating antitumor activity.
  • Both IFN-alpha (type I) and IFN-gamma (type II) signaling, acting through STAT1, are required for effective NK cell-mediated tumor rejection.
  • A STAT1-dependent, but partially IFN-independent pathway contributes to NK cell antitumor immunity.